comparemela.com

Latest Breaking News On - Institute for glycomics professor mark von itzstein - Page 1 : comparemela.com

Griffith University: Griffith University researchers develop vaccine for human babesiosis

Share In a world-first, Griffith University researchers have developed a new vaccine in pre-clinical studies to treat human babesiosis, a tick-transmitted disease closely related to malaria. Lead researcher Professor Michael Good AO, said the research team including PhD candidate Hanan Al-Nazal and researcher Dr Danielle Stanisic, developed a whole parasite Babesia vaccine that acts as a universal vaccine, inducing immunity against different human Babesia species. “Babesiosis affects the red blood cells similar to malaria in humans and animals and presents as a flu-like illness and anaemia. People most at risk of severe disease are the elderly, the immunosuppressed and those without spleens. It also affects those who need blood transfusions,’’ Professor Good said.

Researchers develop vaccine for human babesiosis

Babesia parasites inside red blood cell. Griffith University researchers have developed a new vaccine in pre-clinical studies to treat human babesiosis, a tick-transmitted disease closely related to malaria. Lead researcher Professor Michael Good AO, said the research team including PhD candidate Hanan Al-Nazal and researcher Dr Danielle Stanisic, developed a whole parasite Babesia vaccine that acts as a universal vaccine, inducing immunity against different human Babesia species. “Babesiosis affects the red blood cells similar to malaria in humans and animals and presents as a flu-like illness and anaemia. People most at risk of severe disease are the elderly, the immunosuppressed and those without spleens. It also affects those who need blood transfusions,” Professor Good said.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.